Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog

Category: innovation – Page 197

Startup Skylo seeks to connect millions of devices, vehicles, vessels via satellite

SAN FRANCISCO – Startup Skylo emerged from stealth mode Jan. 21 with $116 million in the bank and plans to connect devices by transferring data over existing geostationary communications satellites.

“The key challenge we wanted to address was how data was going to be moved from machines and sensors outside of the areas where traditionally connectivity has existed,” Parthsarathi “Parth” Trivedi, Skylo co-founder and CEO, told SpaceNews. “If we could lower the cost of providing ubiquitous, affordable and reliable connectivity, there would be a phenomenal number of applications.”

Skylo raised $13 million in a Series A investment round led by DCM Ventures and Innovation Endeavors with participation by Boeing HorizonX and Moore Strategic Ventures. In its latest Series B round led by SoftBank with participation by all the firm’s previous investors, Skylo raised $103 million, according to the firm’s Jan. 21 news release.

Capella Space Unveils Advanced Satellite Design to Deliver High Resolution On-Demand Earth Observation Data

SAN FRANCISCO, Jan. 21, 2020 /PRNewswire/ — Capella Space, an information services company providing Earth observation data on demand, today unveiled its evolved satellite design to enable on-demand observations of anywhere on Earth. Informed by extensive customer feedback and findings from the launch of Denali, Capella’s testbed satellite, the re-engineered design features a suite of technological innovations to deliver timely, flexible and frequent sub-0.5 meter very high quality images to the market. The enhanced technology package will deliver the most advanced offering for small satellite SAR imagery on the market.

LIfT BioSciences secures a further round of funding for its game-changing innate cell therapy for solid tumours

London, 15th January 2020 – Biotech LIfT BioSciences today announced a further major investment into the company in its mission to develop the first curative and affordable cell therapy for all solid tumours. The investors included Jonathan Milner, a leading biotech ‘super-angel’ investor and earlier stage investor in LIfT, Kizoo Technology Ventures, a leading early-stage investor in breakthrough technologies and Downing Ventures, a leading London-based investor.

IOT needs decentralized, long-range connectivity. It’s finally coming

No matter how cheap or fast paid internet service gets, the Internet of Things (IOT) won’t take wings until we have ubiquitous access to a completely decentralized, open-standard network that does not require a provider subscription. This month, we may be a step closer.

Let’s talk about internet connected gadgets. Not just your phone or PC—and not even a microwave oven or light bulb. Instead, think of everyday objects that are much smaller and much less expensive. Think of things that seemingly have no need to talk with you.

Now think of applications in which these tiny things need to communicate with each other and not just with you. Think of the cost of this “thing” compared to the added cost of continuous communications. Do so many things really need to talk in the first place?

First, there were Trackers…

Continue reading “IOT needs decentralized, long-range connectivity. It’s finally coming” | >

Researchers decipher a new way that immune cells detect infections and cancers

Published today in Science, the research team from the Peter Doherty Institute for Infection and Immunity (Doherty Institute), the Olivia Newton-John Cancer Research Institute and CSL Limited say this breakthrough of discovering how gamma-delta T cells become activated addresses a question that has baffled scientists for 25 years.

The study by University of Melbourne’s Marc Rigau, Ph.D. student at the Doherty Institute, was co-led by Dr. Adam Uldrich, a Senior Research Fellow at the Doherty Institute, Professor Dale Godfrey a laboratory head at the Doherty Institute, and Dr. Andreas Behren, a Laboratory Head from the Olivia Newton-John Cancer Research Institute.

Dr. Uldrich explained that gamma-delta T cells are known to respond to the presence of small molecules, known as phosphoantigens, that are produced by bacteria and .

/* */